Literature DB >> 18679828

Evidence for an ancient BRCA1 mutation in breast cancer patients of Yoruban ancestry.

Bifeng Zhang1, James D Fackenthal, Qun Niu, Dezheng Huo, Walmy E Sveen, Tiffani DeMarco, Clement A Adebamowo, Temidayo Ogundiran, Olufunmilayo I Olopade.   

Abstract

BACKGROUND: BRCA1 recurrent mutations have rarely been assessed in non-founder populations. Still, identifying such mutations could be important for designing genetic testing strategies for high-risk breast/ovarian cancer families in non-founder populations.
OBJECTIVE: To determine whether the recurrent BRCA1 Y101X mutation identified in Yoruban breast cancer patients represents a single historical mutation event, and determine the prevalence of this mutation in a hospital based cohort.
METHODS: 365 breast cancer patients and 177 controls of Yoruban ancestry from Nigeria, unselected for age of onset or family history were screened for the BRCA1 Y101X mutation. The haplotypes on which the Y101X mutation occurred were characterized using microsatellite markers and single-nucleotide polymorphisms (SNPs). Phase ambiguity was resolved using allele-specific PCR.
RESULTS: The BRCA1 Y101X mutation was detected in four Yoruban patients with no documented family history of breast cancer among a cohort of 365 (1.1, 95% C.I. = 0.43-2.78%) unrelated Yoruban breast cancer patients. This study reveals the four Y101X mutations occur on a single, rare haplotype. Further characterization in a patient of European ancestry with a strong family history of breast/ovarian cancer revealed the same Y101X mutation on the same haplotype as those in the Yoruban carriers. These observations suggest the Y101X mutations identified in the Yoruban patients may have originated from a single mutation event.
CONCLUSIONS: BRCA1 Y101X is the first reported recurrent mutation occurring in patients of African ancestry for which prevalence has been determined. Identification of this mutation in a woman of European ancestry with strong family history of breast/ovarian suggests further that this mutation occurred once, probably many generations ago.

Entities:  

Mesh:

Year:  2008        PMID: 18679828     DOI: 10.1007/s10689-008-9205-9

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  26 in total

1.  The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation.

Authors:  A Bergman; Z Einbeigi; U Olofsson; Z Taib; A Wallgren; P Karlsson; J Wahlström; T Martinsson; M Nordling
Journal:  Eur J Hum Genet       Date:  2001-10       Impact factor: 4.246

2.  A comparison of bayesian methods for haplotype reconstruction from population genotype data.

Authors:  Matthew Stephens; Peter Donnelly
Journal:  Am J Hum Genet       Date:  2003-10-20       Impact factor: 11.025

3.  Complete allelic analysis of BRCA1 and BRCA2 variants in young Nigerian breast cancer patients.

Authors:  J D Fackenthal; L Sveen; Q Gao; E K Kohlmeir; C Adebamowo; T O Ogundiran; A A Adenipekun; R Oyesegun; O Campbell; C Rotimi; E E U Akang; S Das; O I Olopade
Journal:  J Med Genet       Date:  2005-03       Impact factor: 6.318

4.  Three per cent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insA.

Authors:  A Dørum; E Hovig; C Tropé; M Inganas; P Møller
Journal:  Eur J Cancer       Date:  1999-05       Impact factor: 9.162

5.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

6.  BRCA2 germline mutations in male breast cancer cases and breast cancer families.

Authors:  F J Couch; L M Farid; M L DeShano; S V Tavtigian; K Calzone; L Campeau; Y Peng; B Bogden; Q Chen; S Neuhausen; D Shattuck-Eidens; A K Godwin; M Daly; D M Radford; S Sedlacek; J Rommens; J Simard; J Garber; S Merajver; B L Weber
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

7.  Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.

Authors:  S Neuhausen; T Gilewski; L Norton; T Tran; P McGuire; J Swensen; H Hampel; P Borgen; K Brown; M Skolnick; D Shattuck-Eidens; S Jhanwar; D Goldgar; K Offit
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

8.  Obesity and height in urban Nigerian women with breast cancer.

Authors:  Clement A Adebamowo; Temidayo O Ogundiran; Adeniyi A Adenipekun; Rasheed A Oyesegun; Oladapo B Campbell; Effiong U Akang; Charles N Rotimi; Olufunmilayo I Olopade
Journal:  Ann Epidemiol       Date:  2003-07       Impact factor: 3.797

Review 9.  Breast cancer genetics in African Americans.

Authors:  Olufunmilayo I Olopade; James D Fackenthal; Georgia Dunston; Michael A Tainsky; Francis Collins; Carolyn Whitfield-Broome
Journal:  Cancer       Date:  2003-01-01       Impact factor: 6.860

10.  Mutation analysis of the BRCA1 and BRCA2 genes in the Belgian patient population and identification of a Belgian founder mutation BRCA1 IVS5 + 3A > G.

Authors:  K Claes; E Machackova; M De Vos; B Poppe; A De Paepe; L Messiaen
Journal:  Dis Markers       Date:  1999-10       Impact factor: 3.434

View more
  14 in total

1.  Evidence for an ancient BRCA1 pathogenic variant in inherited breast cancer patients from Senegal.

Authors:  Rokhaya Ndiaye; Jean Pascal Demba Diop; Violaine Bourdon-Huguenin; Ahmadou Dem; Doudou Diouf; Mamadou Moustapha Dieng; Pape Saloum Diop; Serigne Modou Kane Gueye; Seydi Abdoul Ba; Yacouba Dia; Sidy Ka; Babacar Mbengue; Alassane Thiam; Maguette Sylla Niang; Papa Madieye Gueye; Oumar Faye; Philomene Lopez Sall; Aynina Cisse; Papa Amadou Diop; Hagay Sobol; Alioune Dieye
Journal:  NPJ Genom Med       Date:  2020-01-31       Impact factor: 8.617

Review 2.  Triple-negative breast cancer in African-American women: disparities versus biology.

Authors:  Eric C Dietze; Christopher Sistrunk; Gustavo Miranda-Carboni; Ruth O'Regan; Victoria L Seewaldt
Journal:  Nat Rev Cancer       Date:  2015-02-12       Impact factor: 60.716

3.  Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women.

Authors:  Luisel Ricks-Santi; J Tyson McDonald; Bert Gold; Michael Dean; Nicole Thompson; Muneer Abbas; Bradford Wilson; Yasmine Kanaan; Tammey J Naab; Georgia Dunston
Journal:  Ethn Dis       Date:  2017-04-20       Impact factor: 1.847

4.  The influence of DNA sequence on epigenome-induced pathologies.

Authors:  Richard B Meagher; Kristofer J Müssar
Journal:  Epigenetics Chromatin       Date:  2012-07-20       Impact factor: 4.954

5.  BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry.

Authors:  Tara M Friebel; Irene L Andrulis; Judith Balmaña; Amie M Blanco; Fergus J Couch; Mary B Daly; Susan M Domchek; Douglas F Easton; William D Foulkes; Patricia A Ganz; Judy Garber; Gord Glendon; Mark H Greene; Peter J Hulick; Claudine Isaacs; Rachel C Jankowitz; Beth Y Karlan; Judy Kirk; Ava Kwong; Annette Lee; Fabienne Lesueur; Karen H Lu; Katherine L Nathanson; Susan L Neuhausen; Kenneth Offit; Edenir I Palmero; Priyanka Sharma; Marc Tischkowitz; Amanda E Toland; Nadine Tung; Elizabeth J van Rensburg; Ana Vega; Jeffrey N Weitzel; Gemo Study Collaborators; Kent F Hoskins; Tara Maga; Michael T Parsons; Lesley McGuffog; Antonis C Antoniou; Georgia Chenevix-Trench; Dezheng Huo; Olufunmilayo I Olopade; Timothy R Rebbeck
Journal:  Hum Mutat       Date:  2019-07-03       Impact factor: 4.700

6.  Evidence for an ancient BRCA1 pathogenic variant in inherited breast cancer patients from Senegal.

Authors:  Rokhaya Ndiaye; Jean Pascal Demba Diop; Violaine Bourdon-Huguenin; Ahmadou Dem; Doudou Diouf; Mamadou Moustapha Dieng; Pape Saloum Diop; Serigne Modou Kane Gueye; Seydi Abdoul Ba; Yacouba Dia; Sidy Ka; Babacar Mbengue; Alassane Thiam; Maguette Sylla Niang; Papa Madieye Gueye; Oumar Faye; Philomene Lopez Sall; Aynina Cisse; Papa Amadou Diop; Hagay Sobol; Alioune Dieye
Journal:  NPJ Genom Med       Date:  2020-01-31       Impact factor: 8.617

Review 7.  A Review of Cancer Genetics and Genomics Studies in Africa.

Authors:  Solomon O Rotimi; Oluwakemi A Rotimi; Bodour Salhia
Journal:  Front Oncol       Date:  2021-02-15       Impact factor: 5.738

8.  Seventeen years after BRCA1: what is the BRCA mutation status of the breast cancer patients in Africa? - a systematic review.

Authors:  Lawal Abdulrazzaq Oluwagbemiga; Atoyebi Oluwole; Adesunkanmi Abdulrasheed Kayode
Journal:  Springerplus       Date:  2012-12-28

9.  Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.

Authors:  Timothy R Rebbeck; Tara M Friebel; Eitan Friedman; Ute Hamann; Dezheng Huo; Ava Kwong; Edith Olah; Olufunmilayo I Olopade; Angela R Solano; Soo-Hwang Teo; Mads Thomassen; Jeffrey N Weitzel; T L Chan; Fergus J Couch; David E Goldgar; Torben A Kruse; Edenir Inêz Palmero; Sue Kyung Park; Diana Torres; Elizabeth J van Rensburg; Lesley McGuffog; Michael T Parsons; Goska Leslie; Cora M Aalfs; Julio Abugattas; Julian Adlard; Simona Agata; Kristiina Aittomäki; Lesley Andrews; Irene L Andrulis; Adalgeir Arason; Norbert Arnold; Banu K Arun; Ella Asseryanis; Leo Auerbach; Jacopo Azzollini; Judith Balmaña; Monica Barile; Rosa B Barkardottir; Daniel Barrowdale; Javier Benitez; Andreas Berger; Raanan Berger; Amie M Blanco; Kathleen R Blazer; Marinus J Blok; Valérie Bonadona; Bernardo Bonanni; Angela R Bradbury; Carole Brewer; Bruno Buecher; Saundra S Buys; Trinidad Caldes; Almuth Caliebe; Maria A Caligo; Ian Campbell; Sandrine M Caputo; Jocelyne Chiquette; Wendy K Chung; Kathleen B M Claes; J Margriet Collée; Jackie Cook; Rosemarie Davidson; Miguel de la Hoya; Kim De Leeneer; Antoine de Pauw; Capucine Delnatte; Orland Diez; Yuan Chun Ding; Nina Ditsch; Susan M Domchek; Cecilia M Dorfling; Carolina Velazquez; Bernd Dworniczak; Jacqueline Eason; Douglas F Easton; Ros Eeles; Hans Ehrencrona; Bent Ejlertsen; Christoph Engel; Stefanie Engert; D Gareth Evans; Laurence Faivre; Lidia Feliubadaló; Sandra Fert Ferrer; Lenka Foretova; Jeffrey Fowler; Debra Frost; Henrique C R Galvão; Patricia A Ganz; Judy Garber; Marion Gauthier-Villars; Andrea Gehrig; Anne-Marie Gerdes; Paul Gesta; Giuseppe Giannini; Sophie Giraud; Gord Glendon; Andrew K Godwin; Mark H Greene; Jacek Gronwald; Angelica Gutierrez-Barrera; Eric Hahnen; Jan Hauke; Alex Henderson; Julia Hentschel; Frans B L Hogervorst; Ellen Honisch; Evgeny N Imyanitov; Claudine Isaacs; Louise Izatt; Angel Izquierdo; Anna Jakubowska; Paul James; Ramunas Janavicius; Uffe Birk Jensen; Esther M John; Joseph Vijai; Katarzyna Kaczmarek; Beth Y Karlan; Karin Kast; KConFab Investigators; Sung-Won Kim; Irene Konstantopoulou; Jacob Korach; Yael Laitman; Adriana Lasa; Christine Lasset; Conxi Lázaro; Annette Lee; Min Hyuk Lee; Jenny Lester; Fabienne Lesueur; Annelie Liljegren; Noralane M Lindor; Michel Longy; Jennifer T Loud; Karen H Lu; Jan Lubinski; Eva Machackova; Siranoush Manoukian; Véronique Mari; Cristina Martínez-Bouzas; Zoltan Matrai; Noura Mebirouk; Hanne E J Meijers-Heijboer; Alfons Meindl; Arjen R Mensenkamp; Ugnius Mickys; Austin Miller; Marco Montagna; Kirsten B Moysich; Anna Marie Mulligan; Jacob Musinsky; Susan L Neuhausen; Heli Nevanlinna; Joanne Ngeow; Huu Phuc Nguyen; Dieter Niederacher; Henriette Roed Nielsen; Finn Cilius Nielsen; Robert L Nussbaum; Kenneth Offit; Anna Öfverholm; Kai-Ren Ong; Ana Osorio; Laura Papi; Janos Papp; Barbara Pasini; Inge Sokilde Pedersen; Ana Peixoto; Nina Peruga; Paolo Peterlongo; Esther Pohl; Nisha Pradhan; Karolina Prajzendanc; Fabienne Prieur; Pascal Pujol; Paolo Radice; Susan J Ramus; Johanna Rantala; Muhammad Usman Rashid; Kerstin Rhiem; Mark Robson; Gustavo C Rodriguez; Mark T Rogers; Vilius Rudaitis; Ane Y Schmidt; Rita Katharina Schmutzler; Leigha Senter; Payal D Shah; Priyanka Sharma; Lucy E Side; Jacques Simard; Christian F Singer; Anne-Bine Skytte; Thomas P Slavin; Katie Snape; Hagay Sobol; Melissa Southey; Linda Steele; Doris Steinemann; Grzegorz Sukiennicki; Christian Sutter; Csilla I Szabo; Yen Y Tan; Manuel R Teixeira; Mary Beth Terry; Alex Teulé; Abigail Thomas; Darcy L Thull; Marc Tischkowitz; Silvia Tognazzo; Amanda Ewart Toland; Sabine Topka; Alison H Trainer; Nadine Tung; Christi J van Asperen; Annemieke H van der Hout; Lizet E van der Kolk; Rob B van der Luijt; Mattias Van Heetvelde; Liliana Varesco; Raymonda Varon-Mateeva; Ana Vega; Cynthia Villarreal-Garza; Anna von Wachenfeldt; Lisa Walker; Shan Wang-Gohrke; Barbara Wappenschmidt; Bernhard H F Weber; Drakoulis Yannoukakos; Sook-Yee Yoon; Cristina Zanzottera; Jamal Zidan; Kristin K Zorn; Christina G Hutten Selkirk; Peter J Hulick; Georgia Chenevix-Trench; Amanda B Spurdle; Antonis C Antoniou; Katherine L Nathanson
Journal:  Hum Mutat       Date:  2018-03-12       Impact factor: 4.700

10.  Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank.

Authors:  Noura S Abul-Husn; Emily R Soper; Jacqueline A Odgis; Sinead Cullina; Dean Bobo; Arden Moscati; Jessica E Rodriguez; Ruth J F Loos; Judy H Cho; Gillian M Belbin; Sabrina A Suckiel; Eimear E Kenny
Journal:  Genome Med       Date:  2019-12-31       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.